Thursday, August 28, 2008

Agricultural Politics of Drug Policy

Panel Proposal for 2009 Drug Policy Alliance International Conference

Harvey Wiley

Agricultural policies gave forth the existing drug control regimen; this dates back to its milestone of the 1906 U.S. Pure Foods and Drugs Act granting the Bureau of Chemistry of the United States Department of Agriculture (U.S.D.A.) the power to ban a substance from interstate commerce via declaring an ingredient as deleterious to health, and of limiting its jurisdiction to substances within the U.S. Pharmacopoeia from which Tobacco was conveniently dropped 1 year earlier in 1905.

Since the U.S.D.A. was established to promote agricultural commodities, its empowerment would have severely unappreciated detriments regarding the market protection of the most intrinsically toxic yet domestic agricultural commodity of Tobacco from the foreign 'menace' of least toxic Coca.

With the public health thus beneath mercantilism, the consequences have been thus severe for numerous people, entities and interests.

Potential Speakers:

Sharon Y. Eubanks , former prosecutor for the U.S. Department of Justice, and the lead prosecutor for a R.I.C.O. act suit against the major cigarette companies by the U.S. department of justice, who in 2005 resigned in response to the Bush administration’s commands to reduce the proposed settlement by 90%. She gave interviews to CBS about this.

Marialuisa S. Gallozzi is a food, drug and insurance company attorney. Since 1987 she has been with the Washington, D.C. law firm Covington and Burling, long established with food and drug law. In 1988, she was assigned “primary responsibility for advising the [Drug Policy] foundation” according to a letter dated March 1990 appearing in the 1988-1990 Biennial Report of the Drug Policy Foundation (a reform organization) by its Presidents Dr. Arnold S. Trebach and Kevin Zeese, crediting her with giving them valuable advice.

Her activities include that upon GMO plant made pharmaceuticals, as a panelist of “Perils and Pitfalls of Plant Based Pharmaceuticals” with her paper “The U.S. Food Industry’s View of Plant Based Pharmaceuticals”, viewable here.

Her published papers include "Inactive Ingredients in Over-the-Counter Drug Products," Regulatory Affairs FOCUS magazine (August 2002).

She is prominent within insurance law, so described as:

Rising star Marialuisa Gallozzi enters the tables in recognition of her vast experience in asbestos, silica, pharmaceutical and other coverage claims, in addition to insurer insolvencies. Described as “an expert on London insolvency matters and schemes of arrangement,” she works with US, Bermuda and London market insurers and captive insurers. Peers consider her “an intellectually strong negotiator and adviser with excellent judgment.”

No comments: